LONDON (ShareCast) - Specialist healthcare group Ark Therapeutics (LSE: AKT.L - news) jumped today on news of a deal with US medical products distributor Health Care Logistics for Kerraboot, Ark’s leg and foot ulcer treatment. The exclusive pilot distribution and marketing agreement signed by the group’s devices subsidiary, Patient Plus Ltd, is initially for one year.
